RNU6-341P

Across TCGA pan-cancer cohorts, RNU6-341P RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated RNU6-341P data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher RNU6-341P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-341P expression acts as an unfavorable survival marker, although some lineages such as LAML and UCS show a favorable association.

THCA, KIRC, and UCEC are the cancer types where RNU6-341P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	DFS	Tertile	All	0.738	0.942	<.001	68	view →
KIRC	DFS	Tertile	All	0.509	0.684	<.001	59	view →
UCEC	DFS	Median	All	0.557	0.689	.004	48	view →
COAD	DFS	Tertile	All	0.299	0.617	<.001	37	view →
LAML	DFS	Quartile	All	0.736	0.398	<.001	36	view →
UCS	DFS	Tertile	IV	0.832	0.239	.024	24	view →
KIRP	OS	Tertile	All	0.900	0.984	.002	22	view →
READ	DFS	Tertile	IV	0.286	0.711	.001	21	view →
UVM	DFS	Median	III,IV	0.257	0.612	.003	19	view →
ACC	OS	Median	IV	0.777	0.309	.019	18	view →
THYM	DFS	Median	All	0.747	0.972	.007	17	view →
PAAD	DFS	Median	All	0.560	0.377	.017	16	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

RNU6-341P–THCA (DFS)

Open the THCA breakdown →